checkpoint inhibitors in small cell lung cancer (sclc)
Published 7 years ago • 118 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
0:51
challenges associated with implementing immune checkpoint blockade in sclc
-
4:47
immune checkpoint inhibitors in small-cell lung cancer
-
40:21
extending horizons with immune checkpoint inhibitors in small cell lung cancer: 2022 perspectives
-
2:52
immunotherapy treatments for small cell lung cancer (sclc)
-
5:55
checkpoint inhibitor resistance in lung cancer
-
1:26
unmet needs in limited-stage small cell lung carcinoma
-
3:48
overcoming resistance to immune checkpoint inhibitors in nsclc
-
1:23
mechanisms resulting in resistance to checkpoint inhibitors in nsclc
-
3:13
treatment and management of small cell lung cancer (sclc)
-
5:31
novel therapies in small cell lung cancer (sclc): lurbinectedin
-
15:25
immune checkpoint inhibitors in lung cancer: lights and shadows
-
37:43
selective inhibition of oncogenic transcription and other approaches in the treatment of sclc
-
0:51
assessing i-sabr in early or recurrent non-small cell lung cancer
-
8:16
immune checkpoint inhibitor combinations in non-small cell lung cancer
-
2:54
best results ever in the treatment of small cell lung cancer: immunotherapy in primary care
-
12:33
introduction: checkpoint inhibition in non-small cell lung cancer
-
1:37
dr. ready on the benefit of pd-l1 inhibition in sclc
-
1:20
resistance to immune checkpoint blockade in patients with cscc
-
0:43
what are the risk factors for small cell lung cancer (sclc)?